Ocean Power Technologies Expands U.S. and International Deployment Footprint

Maris-Tech Completes Development of Peridot Night Micro for AI-Enhanced Situational Awareness

Alpha Cash is Live - Alpha Modus Unleashes a Fintech App Aimed at the $347 Billion Broken Banking Machine

YY Group (NASDAQ: YYGH) Expands Malaysia Operations to Melaka, Entering New High-Growth Hospitality Market

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead

Ameresco's Kūpono Project Named Winner in 2026 Environment+Energy Leader Awards

Myseum.AI Highlights Continuing Progress on AI Development Roadmap, Technology Advancements and Growth Initiatives in Letter to Shareholders

Safe Pro Awarded Additional U.S. Government Subcontract Modification for Extended Support of AI Powered Edge Processing Systems

Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers

Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026

Cognizant Increases 2026 Share Repurchase Target by $1 Billion to $2 Billion

U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

Digital Realty Opens First Data Center in Barcelona, Strengthening Its Position Across the Mediterranean

As Travelers Hit the Highway During America’s 250th Anniversary, Hilton Celebrates with Unexpected, Unforgettable Road Trips for Just 250 Hilton Honors Points

Clinch Resources Ltd. Announces Participation in THE Mining Investment EVENT, Quebec City, June 2-4, 2026

Enhanced (NYSE: ENHA) Selects Rezolve Ai (NASDAQ: RZLV) to Power AI-Native Live Enhanced Consumer Platform and Digital Fan Ecosystem

Alpha and Omega Semiconductor Unveils Total Power Solution for Next-Gen Intel Panther Lake and Wildcat Lake Platforms

Garrett Motion announces partial repayment and successful repricing of Term Loan

FreeCast Highlights FY2026-2027 Platform Strategy Centered on Satellite and Telecom Streaming Opportunities

Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies